What is the recommended dosing regimen of Z‑Pack (azithromycin) for adults without macrolide allergy or hepatic impairment and for children weighing ≥15 kg?

Z-Pack Dosing Regimen

For adults without macrolide allergy or hepatic impairment, the standard Z-Pack dose is azithromycin 500 mg on day 1, followed by 250 mg once daily on days 2-5 (total 1.5 g over 5 days). For children weighing ≥15 kg, the dose is 10 mg/kg on day 1 (maximum 500 mg), followed by 5 mg/kg once daily on days 2-5 (maximum 250 mg per dose) 1, 2.

Adult Dosing

The evidence consistently supports several azithromycin regimens depending on the clinical indication:

Standard 5-day regimen:

• Day 1: 500 mg once
• Days 2-5: 250 mg once daily
• Total dose: 1.5 g

This is the most commonly prescribed Z-Pack formulation for respiratory tract infections and sexually transmitted diseases 1, 2.

Alternative regimens for specific conditions:

• Single-dose therapy: 1 g orally as a single dose for uncomplicated chlamydial infections 3, 1
• Three-times-weekly dosing: 500 mg three times weekly for chronic conditions like bronchiectasis or MAC lung disease 4, 5
• Short-course therapy: 500 mg daily for 3 days (total 1.5 g) has equivalent efficacy to the 5-day regimen for atypical pneumonia 6

Pediatric Dosing (≥15 kg)

Standard 5-day regimen:

• Day 1: 10 mg/kg once (maximum 500 mg)
• Days 2-5: 5 mg/kg once daily (maximum 250 mg per dose)

This dosing provides sustained systemic exposure with once-daily administration 7. For a 15 kg child, this translates to 150 mg on day 1, then 75 mg daily for days 2-5.

Alternative pediatric regimens:

• Lyme disease (if macrolide necessary): 10 mg/kg per day (maximum 500 mg per day) for 7-10 days 8
• Babesiosis: 10 mg/kg once daily on day 1 (maximum 500 mg), then 5 mg/kg once daily thereafter 8

Important Clinical Considerations

Timing and administration:

• Can be taken with or without food
• Once-daily dosing improves compliance
• First dose should ideally be directly observed when compliance is questionable 1

Common pitfalls to avoid:

1. Dosing errors in small adults: Elderly patients or those <50 kg may require dose reduction to 250 mg daily (rather than 500 mg on day 1) due to gastrointestinal intolerance 4

2. Cardiovascular risk: The FDA issued warnings about QTc prolongation and cardiovascular deaths, particularly in patients with baseline cardiovascular disease 9. Check baseline ECG if QTc concerns exist (contraindicated if QTc >450 ms in men or >470 ms in women) 5

3. Drug interactions: When combined with rifabutin for MAC disease, azithromycin doses should not exceed 250 mg daily due to drug interaction risks 4

4. Resistance concerns: Macrolides should only be used for community-acquired pneumonia in areas where pneumococcal resistance is <25% 2

Abstinence from sexual activity: Patients treated for sexually transmitted infections must abstain for 7 days after single-dose therapy or until completion of multi-day regimens 1.

Pregnancy: Azithromycin is safe in pregnancy and is the preferred macrolide, dosed as 1 g orally as a single dose for chlamydial infections 3.

The tissue concentrations of azithromycin far exceed serum levels (>3 mg/kg in most tissues), with elimination half-lives of 2-3 days in tissues, which supports the shorter dosing regimens 10, 11.